With over 25 years of central laboratory experience, the network currently supports clinical trials in over 85 countries across six continents. Four wholly owned central laboratory sites in the USA, Netherlands, Singapore and China operate under global quality standards, SOPs and IT infrastructure, ensuring data is inherently combinable. A fifth CAP-accredited pathology site in the USA extends those capabilities further. The global footprint of the Eurofins Central Laboratory network ensures specimen integrity, optimal turnaround time for results, manageability of the logistic processes, and control over associated costs.

The global quality system of Eurofins Central Laboratory is designed to encompass the relevant aspects of both international and country-specific quality standards. The quality system of Eurofins Central Laboratory is based on regulatory standards GCLP, GCP, and CLIA, and quality standards CAP, ISO/IEC17025 and ISO15189.